about
Stability of chronic medicines in dosage administration aids. How much have been done?A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population.A systematic review of factors that influence treatment adherence in paediatric oncology patients.The association between distance to public amenities and cardiovascular risk factors among lower income Singaporeans.Association between helplessness, disability, and disease activity with health-related quality of life among rheumatoid arthritis patients in a multiethnic Asian population.Role of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and mean platelet volume (MPV) in assessing disease control in Asian patients with axial spondyloarthritis.Assessing the validity of a data driven segmentation approach: A 4 year longitudinal study of healthcare utilization and mortality.A qualitative study of quality of life domains and subdomains relevant to patients with spondyloarthritisTraditional Chinese medicine (TCM) collaborative care for patients with axial spondyloarthritis (AcuSpA): protocol for a pragmatic randomized controlled trialThe impact of axial spondyloarthritis on quality of life (QoL): a comparison with the impact of moderate to end-stage chronic kidney disease on QoLComplementary and alternative medicine for rheumatic diseases: A systematic review of randomized controlled trialsA cross-sectional study on factors associated with patient-physician discordance in global assessment of patients with axial spondyloarthritis: an Asian perspectiveValidity and reliability of Work Productivity and Activity Impairment among patients with axial spondyloarthritis in SingaporeValidity and reliability of the ten-item Connor-Davidson Resilience Scale (CD-RISC10) instrument in patients with axial spondyloarthritis (axSpA) in SingaporeA cross-sectional study on factors associated with poor work outcomes in patients with axial spondyloarthritis in SingaporeDifferential Health Care Use, Diabetes-Related Complications, and Mortality Among Five Unique Classes of Patients With Type 2 Diabetes in Singapore: A Latent Class Analyses of 71,125 PatientsEvaluation of Mobile Apps Targeted at Patients With Spondyloarthritis for Disease Monitoring: Systematic App SearchValidity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in SingaporeThe direct and indirect costs of axial spondyloarthritis (axSpA) in SingaporeAre extra-spinal symptoms associated with quality of life in patients with axial spondyloarthritis? A 1-year follow-up studyThe mediating role of pain and function in the association between stiffness and quality of life in patients with axial spondyloarthritisA systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditionsFactors associated with patient-physician discordance in a prospective cohort of patients with psoriatic arthritis: An Asian perspectiveCross-cultural adaptation of the Hamilton axial spondyloarthritis questionnaire and development of a Chinese version in a multi-ethnic Asian populationValidity and reliability of the Assessment of Spondyloarthritis International Society Health Index in English-speaking patients with axial spondyloarthritis in SingaporeCalibration of a physical functioning item bank for measurement of health-related quality of life in SingaporeMeasurement properties of Pain Catastrophizing Scale in patients with knee osteoarthritis
P50
Q26768241-BF3B76E7-AC83-42A4-91E8-7AD9FDD337C8Q38662236-479EED4F-821C-4CBB-A47C-5FB997786686Q38854206-E5916A49-397B-4D3C-9D1E-094FD6C1FCAEQ39043410-F93BEDEE-4A5E-4141-B3B0-61D5A74EC5C9Q42255571-0F8571F6-285B-4B35-A41D-04CEF177F54EQ44837395-08834F74-4F4C-4046-A78D-A35DD41F6DFFQ47226769-1FF7A65D-7C4F-4B9B-ADA8-40A8C9A9B352Q52330973-C4A05B8B-DD33-4E16-B9A3-80C90D8755F1Q58581645-605C5A28-9EDD-42C4-9026-063B7F0DD8BBQ60910081-6C38BC27-9F4B-42B0-8995-4438D7AC19E8Q64045142-1DDA9E60-C7EA-4686-926F-CA5307E15B37Q88247771-6AF9F257-8462-4A19-88ED-1F8735CAF39CQ89155637-80660EBE-5A4A-4746-81A3-D40624A91C3BQ89535318-FBF3D089-DF70-486A-BF18-07D422FD225DQ90318971-AF6725E5-AB99-4B6E-A6DA-78620D52F72DQ90430916-597CA3A4-E11B-4AD2-B561-9F8A1AE3AE69Q90437814-C3D56BD1-BCAC-4EF6-84FD-65956F133DE1Q90984633-F20575D8-AEEF-4B5D-BB6E-EFBA3F8185CEQ91266456-08BF666A-79B6-4A55-B575-B66B16FC1F20Q92428711-636C5615-2DCB-4746-9D1E-637845570F45Q92566262-73C94014-3A39-4D59-93A1-4D8FB1B579DBQ92578975-A01A42D5-9D5F-49AB-AC61-8F33DC731E47Q92714001-39639F5E-BD00-4C26-ACDE-BEC043F22BA8Q92815967-B6AE7796-9A8C-4273-A5B3-3CB8D73CC166Q93069127-D227C6AF-2556-4410-9C50-728B413C2006Q93069174-0213337B-3C5D-4C74-82C9-350D8A8A2A29Q95661529-AE79B4D0-87B5-4DE0-B8B4-D326AF99B394Q96232169-4FC2FDF8-873D-4AE2-A348-A4AFF5E1937D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yu Heng Kwan
@ast
Yu Heng Kwan
@en
Yu Heng Kwan
@es
Yu Heng Kwan
@nl
Yu Heng Kwan
@sl
type
label
Yu Heng Kwan
@ast
Yu Heng Kwan
@en
Yu Heng Kwan
@es
Yu Heng Kwan
@nl
Yu Heng Kwan
@sl
prefLabel
Yu Heng Kwan
@ast
Yu Heng Kwan
@en
Yu Heng Kwan
@es
Yu Heng Kwan
@nl
Yu Heng Kwan
@sl
P106
P1153
55986108400
P31
P496
0000-0001-7802-9696